BridgeBio is significantly boosted its progress of an new therapy read more for ATTR-CM, leveraging Attruby. Preliminary clinical data indicates potential outcomes for patients suffering by a serious disease. The effort represents the company’s dedication to treating unmet patient needs in this heart arena. Attruby: BridgeBio's Novel Approach to